We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Neurocognitive battery possible in 3-year-olds throughout leukemia remedy
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Neurocognitive battery possible in 3-year-olds throughout leukemia remedy
Neurocognitive battery possible in 3-year-olds throughout leukemia remedy
Health

Neurocognitive battery possible in 3-year-olds throughout leukemia remedy

Last updated: December 19, 2024 3:44 am
Editorial Board Published December 19, 2024
Share
SHARE

A short neurocognitive battery is possible to be used in 3-year-olds throughout acute lymphoblastic leukemia remedy, in line with a research printed on-line Dec. 9 in Pediatric Blood & Most cancers.

Sameera Ramjan, from Memorial Sloan Kettering Most cancers Heart in New York Metropolis, and colleagues provided sufferers enrolled within the Remedy of Newly Identified Acute Lymphoblastic Leukemia in Youngsters and Adolescents participation in an non-compulsory neurocognitive research assessing longitudinal modifications in neurocognitive perform. The evaluation included 3- and 4-year-old sufferers enrolled within the research.

The researchers discovered that 3-year-old sufferers didn’t differ from 4-year-olds by way of their potential to carry out or full the temporary Cogstate battery assessing psychomotor perform (detection) and a spotlight (identification). These findings endured at 4 time-point assessments, by means of 52 weeks after prognosis.

“This report demonstrates that computerized testing, such as Cogstate, can be successfully administered to 3-year-old patients who are undergoing treatment for acute lymphoblastic leukemia, thereby capturing serial test data on a vulnerable patient population that, in prior studies, have demonstrated worse neurocognitive deficits,” the authors write.

“Consequently, changing future study inclusion criteria to include patients diagnosed at the age of 3 years will ultimately serve to improve our understanding of at-risk patients and the neurocognitive trajectory of this age group both during treatment as well as into survivorship, thereby leading to the development of early interventions.”

One creator disclosed ties to the pharmaceutical trade; two authors disclosed ties to Cogstate.

Extra data:
Sameera Ramjan et al, Feasibility of Using a Transient Neurocognitive Battery in 3‐Yr‐Previous Sufferers Throughout Remedy for Acute Lymphoblastic Leukemia, Pediatric Blood & Most cancers (2024). DOI: 10.1002/pbc.31469

Quotation:
Neurocognitive battery possible in 3-year-olds throughout leukemia remedy (2024, December 18)
retrieved 18 December 2024
from https://medicalxpress.com/information/2024-12-neurocognitive-battery-feasible-year-olds.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Biking in an MRI machine may assist physicians to verify your coronary heart well being

Q&A: Fearful about getting a CT scan? This is what to ask your physician

Rising numbers of US adults do not know they’ve diabetes, hypertension or excessive ldl cholesterol

Zebrafish mannequin for an ultra-rare genetic illness reveals two promising drug candidates

Canada toddler born with measles from unvaccinated mom dies

TAGGED:3yearoldsbatteryfeasibleLeukemiaNeurocognitivetreatment
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Typically, issues actually do appear higher within the morning, massive research suggests
Health

Typically, issues actually do appear higher within the morning, massive research suggests

Editorial Board February 5, 2025
Begin of US looking season linked to elevated firearm incidents, together with violent crimes and suicide
What’s Albany, OR Recognized For? 7 Issues to Love About This Metropolis
Cholera outbreak in Sudan capital kills 70 in 2 days: well being ministry
A Cockney Rosebud: New Bittersweet and Poignant Memoir Captivates with Tale of Early 20th Century East End Family Life

You Might Also Like

Ivory Coast declares cholera outbreak after 7 deaths
Health

Ivory Coast declares cholera outbreak after 7 deaths

June 5, 2025
Metabolic markers present in overweight adolescents information vascular getting older intervention
Health

Metabolic markers present in overweight adolescents information vascular getting older intervention

June 5, 2025
ASCO: Durvalumab plus FLOT useful for resectable gastric, GE junction most cancers
Health

ASCO: Durvalumab plus FLOT useful for resectable gastric, GE junction most cancers

June 5, 2025
Experiencing sacred moments is widespread for inner drugs docs
Health

Experiencing sacred moments is widespread for inner drugs docs

June 5, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?